Skip to main content
RedHill Biopharma Ltd. logo

RedHill Biopharma Ltd. — Investor Relations & Filings

Ticker · RDHL ISIN · US7574681034 LEI · 52990034U7FZBKRAOE32 US Manufacturing
Open in API
Filings indexed 993 across all filing types
Latest filing 2014-05-01 Regulatory Filings
Country IL Israel
Listing US RDHL

About RedHill Biopharma Ltd.

https://www.redhillbio.com/

RedHill Biopharma is a specialty biopharmaceutical company focused on the development and commercialization of proprietary, orally-administered, small molecule drugs. The company's primary therapeutic areas of focus are gastrointestinal (GI) diseases, infectious diseases, and oncology. Its key commercial product is Talicia® for the treatment of Helicobacter pylori (H. pylori) infection. RedHill's late-stage clinical development pipeline includes several drug candidates. Among these are Opaganib, a broad-acting, host-directed antiviral and anti-inflammatory agent; RHB-204 for pulmonary nontuberculous mycobacteria (NTM) disease; and RHB-107 (upamostat), an oral serine protease inhibitor. A significant part of its strategy involves developing its assets for pandemic preparedness and as medical countermeasures, emphasizing therapies with viral mutation-resistant properties suitable for stockpiling.

Recent filings

Filing Released Lang Actions
FORM 6-K FILING DOCUMENT
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filing by RedHill Biopharma Ltd., which is a report of a foreign private issuer pursuant to SEC rules. It includes a press release about a presentation at the ChinaBio Partnering Forum 2014. The document is short (2263 characters) and primarily serves as an announcement of the press release rather than containing detailed financial data or comprehensive report content. Form 6-K filings typically serve as periodic reports for foreign issuers and often include press releases or other material information. Given the length and content, this document is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories and includes Form 6-K filings that are announcements rather than full reports.
2014-05-01 English
FORM 6-K
Interim / Quarterly Report Classification · 95% confidence The document is a Form 6-K filed by a foreign private issuer, RedHill Biopharma Ltd., with the SEC. It includes a press release reporting results for the first quarter of 2014 and condensed interim unaudited financial information for the three months ended March 31, 2014. Form 6-K is typically used by foreign private issuers to report interim financial information and other material events between annual reports. The document length is short (2014 characters), and it contains actual financial data (interim unaudited financial information). Therefore, it qualifies as an Interim / Quarterly Report (IR) rather than just an announcement or regulatory filing. It is not a full annual report (10-K), nor a simple announcement or certification. Hence, the correct classification is IR with high confidence.
2014-04-30 English
FORM 6-K FILING DOCUMENT
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filing submitted by a foreign private issuer, RedHill Biopharma Ltd., to the SEC. It includes a press release about a clinical trial and planned marketing application submission. Form 6-K filings are periodic reports for foreign private issuers to disclose material information between annual reports (Form 20-F or 40-F). The document is short (2343 characters) and primarily serves as a regulatory announcement rather than a full financial report or detailed presentation. It does not contain financial statements or detailed management discussion. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and filings that do not fit other specific categories.
2014-04-30 English
FORM 6-K
AGM Information Classification · 95% confidence The document is a Form 6-K filed by a foreign private issuer, Redhill Biopharma Ltd., reporting resolutions approved at the Annual General Meeting (AGM) held on April 30, 2014. The content includes appointment of auditors, re-election of board members, approval of employment terms for executives, and approval of compensation and option grants for non-executive directors. These are typical materials shared during an AGM. The document length is 3121 characters, which is relatively short and focused on AGM resolutions rather than a full annual report or financial statements. Therefore, this document fits the category of AGM Information (AGM-R).
2014-04-30 English
FORM 6-K FILING DOCUMENT
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filing by a foreign private issuer, RedHill Biopharma Ltd., submitted to the SEC. It includes a press release announcing a conference call for first quarter 2014 financial results. The document is short (2292 characters) and primarily serves as an announcement of an upcoming earnings call rather than containing actual financial results or detailed financial data. According to the rules, such announcements are not classified as Earnings Releases (ER) or Call Transcripts (CT) but rather as Regulatory Filings (RNS) since it does not contain substantive financial data or the transcript itself. Therefore, the appropriate classification is Regulatory Filings (RNS).
2014-04-29 English
FORM 6-K FILING DOCUMENT
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filing, which is a report of a foreign private issuer submitted to the SEC. It includes a press release about the commencement of a bioavailability study and references regulatory filings but does not contain detailed financial statements or comprehensive financial analysis. The document length is short (2365 characters), and it primarily serves as an announcement of information rather than a full report. According to the rules, such filings that provide updates or announcements without substantive financial data or detailed reports are best classified as Regulatory Filings (RNS).
2014-04-28 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.